Prevention & Chronic Conditions


Cardiovascular disease (CVD) is a significant and ever-growing problem in the UK, accounting for nearly one-third of all deaths and leading to significant morbidity. Globally CVD accounts for 31% of mortality, mainly from heart disease and cerebrovascular accident.

The burden of CVD can be ameliorated by careful risk modification and primary prevention is an important priority for all developers of health policy. Strong consensus exists between international guidelines regarding the necessity of smoking cessation, weight optimisation and exercise, although guidelines have slightly different approaches to hypertension and vary considerably regarding their approach to optimal lipid profile, which remains a contentious issue.


Effect of PCI on HRV in CAD patients


European Cardiology Review 2018;13(1):60–1.

Treatment Selection in Pulmonary Arterial Hypertension: Phosphodiesterase Type 5 Inhibitors versus Soluble Guanylate Cyclase Stimulator


European Cardiology Review 2018;13(1):35–7.

New Advances in the Management of Refractory Angina Pectoris


European Cardiology Review 2018;13(1):70–9.

Guest Editorial: Is Cardio-oncology Ready for Algorithms?


European Cardiology Review 2018;13(1):62–3.